GTC Biotherapeutics (fka GTCB)

[jessellivermore]

AT3 and ischemia II

In addition to the Cuomo paper on the ameleoration of CNS damage 2ndary to ischemia by AT3 there are a raft of other papers describing other ischemic conditions which are improved by AT3.

Cuomo's paper ends with his statment he feels AT3 should be used in humans post thrombotic stroke.. I wonder if anyone in the company or on this board has contacted him to find if he has or is planning to try this. IMHO Atryn's eventual effectiveness in stroke and heart attack is more of a sure thing than is the DIC indication (which IMHO has a high likelyhood of success) DIC may turn out to be hard to dose and hard to time the dosing due to the greater fluidity of the clinical situation..... eg. give AT3 too early in DIC and you might make the the situation worse,,,, In ishemia the event is more easily defined..... AT3 is given after the event.